Average Co-Inventor Count = 4.32
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (18 from 3,681 patents)
2. Bristol Meyers Squibb Company (1 from 41 patents)
19 patents:
1. 12331045 - Substituted phenyl oxazolone compounds
2. 11548870 - Compounds useful as inhibitors of helios protein
3. 11485741 - Macrocyclic toll-like receptor 7 (TLR7) agonists
4. 10550125 - Prodrugs of imidazotriazine compounds as CK2 inhibitors
5. 10196387 - Carbazole compounds useful as bromodomain inhibitors
6. 10053454 - Carbazole compounds useful as bromodomain inhibitors
7. 9822103 - Inhibitors of lysine methyl transferase
8. 9738630 - Inhibitors of lysine methyl transferase
9. 9593116 - Crystalline forms of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide for the treatment of myeloproliferative disorders
10. 9556178 - Imidazotriazinecarbonitriles useful as kinase inhibitors
11. 9273057 - Imidazotriazinecarbonitriles useful as kinase inhibitors
12. 8940736 - Imidazotriazinecarbonitriles useful as kinase inhibitors
13. 8815840 - Carbazole and carboline kinase inhibitors
14. 8673933 - JAK2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
15. 8445676 - Pyrrolotriazine kinase inhibitors